Fertility outcome of hyperprolactinemic infertile women undergoing induction of ovulation for intrauterine insemination (IUI): A comparison between Bromocriptine and Cabergoline.

Trial Profile

Fertility outcome of hyperprolactinemic infertile women undergoing induction of ovulation for intrauterine insemination (IUI): A comparison between Bromocriptine and Cabergoline.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Bromocriptine (Primary) ; Cabergoline (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2011 Official title amended, actual initiation date (Mar 2005) added as reported by ClinicalTrials.gov.
    • 25 Aug 2011 New source identified and integrated (Iranian Registry of Clinical Trials; IRCT138806142420N1).
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top